AI Article Synopsis
- The 2023 European Society of Cardiology guidelines for acute coronary syndrome emphasize updated management strategies for better clinical outcomes.
- The review highlights specific practices in the Netherlands, such as pre-treatment protocols and antiplatelet agent strategies tailored to patient needs.
- It also covers the importance of risk scoring and the logistical aspects of scheduling coronary angiography to improve patient care efficiency.
Article Abstract
This review discusses the new recommendations in the 2023 European Society of Cardiology guidelines on the management of acute coronary syndrome and provides a perspective on topics specific to clinical practice in the Netherlands, including pre-treatment, antiplatelet agent strategies, the use of risk scores and logistical considerations with regard to the timing of coronary angiography.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413259 | PMC |
| http://dx.doi.org/10.1007/s12471-024-01896-2 | DOI Listing |
Publication Analysis
Top Keywords
2023 european
8
european society
8
society cardiology
8
cardiology guidelines
8
guidelines management
8
management acute
8
acute coronary
8
coronary syndromes
4
syndromes statement
4
statement endorsement
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!